Catalent 1Q12 1Q Revenues: $410.5 million (+8%) 1Q Loss: $5.2 million (loss of $28.8 million 1Q11) Comments: Oral Technologies revenue was $274.9 million (+13%), driven by continued demand for Rx softgel products and controlled release products. Sterile Technologies revenue was $52.7 million (-2%), due to lower flu and non-flu demand. Packaging Services revenue was $40.7 million (-12%), impacted by property and casualty loss at the company’s UK-based commercial packaging facility. Development...